Quarterly Financial Information (Unaudited) (Tables)

12 Months Ended

Dec. 31, 2017

Quarterly Financial Information Disclosure [Abstract]

Schedule of Quarterly Financial Information

Selected quarterly financial information for each of the quarters in the years ended December 31, 2017 and 2016 is as follows:

	Quarter
2017	First			Second			Third			Fourth
Patient revenues, net	$	141,500,000		$	142,550,000		$	146,377,000		$	144,367,000
Professional liability expense (1)	2,670,000			2,724,000			2,617,000			2,753,000
Income (loss) from continuing operations	1,348,000			381,000			(581,000		)	(5,947,000		)
Income (loss) from discontinued operations	(15,000		)	(28,000		)	1,000			14,000
Net income (loss)	$	1,333,000		$	353,000		$	(580,000	)	$	(5,933,000	)
Basic net income (loss) per common share:
Income (loss) from continuing operations	$	0.22		$	0.06		$	(0.09	)	$	(0.94	)
Loss from discontinued operations	—			—			—			—
Net income (loss) per common share	$	0.22		$	0.06		$	(0.09	)	$	(0.94	)

Diluted net income (loss) per common share:
Income (loss) from continuing operations	$	0.21	$	0.06	$	(0.09	)	$	(0.94	)
Loss from discontinued operations	—		—		—			—
Net income (loss) per common share	$	0.21	$	0.06	$	(0.09	)	$	(0.94	)

(1) The Company's quarterly results are significantly affected by the amounts recorded for professional liability expense, as discussed further in Note 9, "Commitments and Contingencies". The amount of expense recorded for professional liability in each quarter of 2017 is set forth in the table above.

	Quarter
2016	First			Second			Third			Fourth
Patient revenues, net	$	97,945,000		$	95,805,000		$	97,313,000		$	135,000,000
Professional liability expense (1)	2,066,000			1,934,000			1,977,000			2,479,000
Income (loss) from continuing operations	(74,000		)	(2,150,000		)	(958,000		)	1,438,000
Loss from discontinued operations	(37,000		)	—			(17,000		)	(13,000		)
Net income (loss)	$	(111,000	)	$	(2,150,000	)	$	(975,000	)	$	1,425,000
Basic net income (loss) per common share:
Income (loss) from continuing operations	$	(0.01	)	$	(0.35	)	$	(0.16	)	$	0.24
Loss from discontinued operations	(0.01		)	—			—			—
Net income (loss) per common share	$	(0.02	)	$	(0.35	)	$	(0.16	)	$	0.24

Diluted net income (loss) per common share:
Income from continuing operations	$	(0.01	)	$	(0.35	)	$	(0.16	)	$	0.24
Loss from discontinued operations	(0.01		)	—			—			—
Net income (loss) per common share	$	(0.02	)	$	(0.35	)	$	(0.16	)	$	0.24

(1) The Company's quarterly results are significantly affected by the amounts recorded for professional liability expense, as discussed further in Note 9, "Commitments and Contingencies". The amount of expense recorded for professional liability in each quarter of 2016 is set forth in the table above.